Never Mind Covid, Investors Want a Pfizer Obesity Pill October 31, 2023 0 Some of this year’s best performers in the healthcare sector are companies expected to profit from the anti-obesity drug craze, ...
Banks Face Shake-Up of Low-Income Lending Rules October 24, 2023 0 Updated Oct. 24, 2023 12:28 pm ETWASHINGTON—Top U.S. banking regulators struggled for more than five years to update anti-redlining rules ...
The Score: Netflix, Tesla, United Airlines and More Stocks That Defined the Week October 20, 2023 0 The Score is a weekly review of the biggest stock moves and the news that drove them.Rite AidRite Aid filed for ...
The Next Hot Obesity Drug Won't Be Approved for Years. Online Sellers Hawk It Anyway. October 20, 2023 0 Eli Lilly’s retatrutide will be in clinical trials for the next three years, but knockoff versions already abound. Source link
Ozempic Boom Is an Opportunity for Health Insurers October 20, 2023 0 You would think a new class of high-price weight loss drugs taken by millions of Americans would be a problem ...
UAW Threatens Strikes at Certain Plants if It Can't Reach Labor Deals September 13, 2023 0 The union plans to hold targeted strikes at certain U.S. auto factories if it can’t reach new labor deals with ...
Ozempic Settles the Obesity Debate: It's Biology Over Willpower August 14, 2023 0 Weight-loss drugs affect the brain in ways that help researchers understand how the body regulates weight. Source link
Can San Francisco Save Itself From the Doom Loop? August 13, 2023 0 The city is racing to come up with solutions for its downtown, hollowed out by a tech exodus and struggling ...
Starbucks Prevails in Legal Challenge to Its Diversity Policies August 12, 2023 0 Decision in federal court in Spokane, Wash., is a setback for legal activists who have sought to unwind companies’ policies ...